Lupin launches generic Nitazoxanide tablets

Nitazoxanide tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia

108
Medicine Tablet
Picture: Pixabay

Last Updated on March 11, 2021 by The Health Master

Global pharma major, Lupin Limited announced the launch of the authorized generic version of Alinia (nitazoxanide) tablets, 500 mg of Romark Laboratories, L.C.

Nitazoxanide tablets, 500 mg, are indicated in the treatment of diarrhea caused by Giardia lamblia or cryptosporidium parvum in patients 12 years of age and older.

Nitazoxanide tablets, 500 mg had estimated annual sales of US$ 56 million in the US, according to IQVIA MAT January 2021.


Also read:

World’s most expensive drug, costs ₹18 crore per dose

NATCO gets USFDA nod for Breast Cancer treatment drug

Kite gets USFDA nod for drug to treat Follicular Lymphoma

Shilpa Medicare gets USFDA tentative nod for drug for Arthritis

Aleor Dermaceuticals gets USFDA nod for Testosterone Gel

Unichem gets USFDA nod for Guanfacine Tablets

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner